Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$83.4M
2 rounds on record
Latest round
$37.5M
Venture round · Jan 2025 · 20 mo ago
Team
16
US Form 5500 (plan participants) · Dec 2025 · +23% in a year
Backers
1
Taiho Ventures
The money's age
Due for its next round
20 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jan 2025 $37.5M — SEC Form D
Venture round Jan 2022 $45.9M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Normunity Holding Company, LLC sec
Founders and leadersfrom filings, registers and the company's site
Rachel HumphreyExecutive Officer, DirectorSEC Form D
Scott PhillipsExecutive OfficerSEC Form D
Darlene Deptula-HicksExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
CytosolixVenture round $6.6M · 3 yr ago • 11-50 employees
Our Tumor Activated Permeability (TAP) Platform produces weakly-acidic derivatives of known oncology drugs that already work. It preserves…
Kumquat BiosciencesVenture round $30M · 5 yr ago • Founded 2018 • 201-500 employees
Innovating life-changing medicines for cancer patients. At Kumquat, we're on a mission to transform cancer treatment by delivering durable…
Frontier Medicines is boldly advancing science to defeat disease by pioneering innovations in precision-based medicines to target…
3T BiosciencesFounded 2017 • 51-200 employees
We are solving a major bottleneck in the field of targeted biotherapeutics in oncology – the identification of novel targets for the…
G1 TherapeuticsVenture round $50M · 10 yr ago • 51-200 employees
G1 Therapeutics, Inc. is a commercial stage oncology company focused on the development and commercialization of next generation therapies…
Humane Genomics develops cancer therapies by engineering cancer-killing RNA viruses using a synthetic biology platform.

Overview

We create medicines that free normal immunity to defeat cancer using proprietary platforms that uncover novel immuno-oncology mechanisms.

People

Rachel Humphrey
Executive Officer, Director
Scott Phillips
Executive Officer
Darlene Deptula-Hicks
Executive Officer
Timothy Shannon
Director
Yunxia Yang
Director
James Trenkle
Director
Sakae Asanuma
Director
David Parry
Director
Sara Nayeem
Director
Marie-Claire Peakman
Director
Paulina Hill
Director
Debanian Ray
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
3
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Westport United States
HQ
New Haven United States
Engineering / R&D
Normunity Office and labs
101 College Street, New Haven, CT 06510
company site
Boston United States
Normunity Corporate Office
1 Beacon St., 15th Floor, Boston, MA 02108
company site

Financials

Total raised
$83.4M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $37.5M Details
Venture - Series Unknown 2022 $45.9M Details